Skip to content
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH
Home
Amicus Briefs
Biosimilars Council Press Releases
Amicus Briefs
Amicus Briefs
September 6, 2024
AAM
Amarin v. Hikma
Amicus Briefs
October 22, 2021
AAM
GLAXOSMITHKLINE LLC and SMITHKLINE BEECHAM (CORK) LIMITED v. TEVA PHARMACEUTICALS USA, INC.
Amicus Briefs
December 2, 2020
AAM
U.S. v. Arthrex
Amicus Briefs
June 18, 2020
AAM
TC HEARTLAND, LLC D/B/A HEARTLAND FOOD PRODUCTS GROUP v. KRAFT FOODS GROUP BRANDS LLC
Amicus Briefs
June 18, 2020
AAM
SAINT REGIS MOHAWK TRIBE and ALLERGAN, INC. v. MYLAN PHARMACEUTICALS, INC ., TEVA PHARMACEUTICALS USA, INC., and AKORN, INC.
Amicus Briefs
June 18, 2020
AAM
AMGEN INC., AMGEN MANUFACTURING LIMITED v. SANDOZ INC.
Amicus Briefs
June 18, 2020
AAM
MYLAN PHARMACEUTICALS INC., TEVA PHARMACEUTICALS USA, INC., and AKORN INC., Petitioners v. ALLERGAN, INC., Patent Owner
Amicus Briefs
June 18, 2020
AAM
MOMENTA PHARMACEUTICALS, INC. v. BRISTOL-MYERS SQUIBB COMPANY
Amicus Briefs
June 18, 2020
AAM
HELSINN v. TEVA
Amicus Briefs
June 18, 2020
AAM
OIL STATES ENERGY SERVICES, LLC, PETITIONER v. GREENE’S ENERGY GROUP, LLC, ET AL.
Amicus Briefs
May 14, 2020
AAM
AAM SUPPORTING PETITIONERS ON SEVERABILITY
Amicus Briefs
June 13, 2019
AAM
PFIZER, INC. v. JOHNSON & JOHNSON and JANSSEN BIOTECH, INC.
Resources
2025 Savings Report
2025 Advocacy Priorities
2025 First Generics White Paper
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Community Commitment
Careers
Contact Us
Advocacy & Policy
Federal Advocacy
Biosimilars
GDUFA/BsUFA User Fees
Inflation Reduction Act
Intellectual Property & Patent Reform
Medicaid Generics Penalty
State Advocacy
Tariffs & Trade
Events
Access! 2026
GRx+Biosims 2026
Press Releases
JOIN
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH